The US Preventive Services Task Force (USPSTF) recommends breast cancer screening every two years for individuals aged 50-74 (Grade B recommendation). For those aged 40-49, screening receives a Grade C recommendation. The USPSTF emphasizes that the decision to start screening between ages 40-49 should be individualized, particularly for those who prioritize the potential benefits over potential harms. Notably, individuals with a first-degree relative with breast cancer may derive more benefit from early screening.

Analysis reveals the most significant reduction in breast cancer-related deaths over a decade among individuals aged 60-69 (21 fewer deaths per 10,000 screened), followed by those aged 50-59 (8 per 10,000), and 3 per 10,000 for those aged 40-49. However, it's crucial to consider false positives, overdiagnosis, and overtreatment when assessing the overall impact of breast cancer screening.

Furthermore, it's worth noting that mammography exhibits lower sensitivity in detecting breast cancer among individuals with dense breast tissue, adding complexity to screening strategies.